Savara Inc. Updates Corporate Presentation (Regulation FD Disclosure)

What Happened

• Savara Inc. (NASDAQ: SVRA) filed a Form 8-K on January 9, 2026 (Item 7.01) reporting a Regulation FD disclosure: the company updated its corporate presentation and furnished it as Exhibit 99.1 to the filing.
• The presentation is available on Savara’s Investor Relations page (https://investors.savarapharma.com/overview/default.aspx). The company states it has no obligation to update the presentation but may do so via its website, future SEC filings, press releases, or other public disclosures.

Key Details

• Filing date: January 9, 2026; filing included Exhibit 99.1 (corporate presentation).
• Presentation posted on Savara’s Investor Relations web page for public access.
• Company disclaimed any duty to update the presentation but may revise it over time.
• The Form 8-K also includes the interactive cover page XBRL file (Exhibit 104).

Why It Matters

• This is a routine Regulation FD disclosure making Savara’s most recent investor presentation publicly available so all investors have equal access to the company’s messaging and materials.
• Investors should review the presentation for the latest overview of Savara’s business, programs, strategy, and timelines; the 8-K does not report earnings, executive changes, or other material events beyond the updated presentation.